Sun Pharmaceutical Industries' key products/revenue segments include Pharmaceuticals which contributed Rs 9783.29 crore to sales value (94.95 percent of total sales) and Other Operating Revenue which contributed Rs 519.92 crore to sales value (5.04 percent of total sales)for the year ending March 31, 2019. It is going bullish with a stop loss of 390 rs and takes profit at 450 rs.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。